Pratt et al. Haemostasis Mar.-Apr. 1998, 28(2), 78-85.* |
Physician' s Desk Reference, 1995, 49th Edition, Medical Economics Data Production Company, Montvale, New Jersey, pp. 1968-1969.* |
Bes, et al., “Medical Therapeutic Strategy of Acute Cerebral Ischaemia in Adults,”J. Neuroradiol, 20, 102-120 (1993). |
Van Gijn, “Thrombolysis in Ischemic Stroke: Double or Quits?.” Circulation, 93, 1616-17 (1996). |
Marx, “Die Therapie des Akuten Ischamischen Insultes,” Hamostaseologie, 17, 86-91 (1997). In German. |
Fareed et al., “Comparative Study on the in vitro and in vivo Activities of Seven Low-Molecular-Weight Heparius,” Haemostasis, 18 (suppl. 3), 3-15 (1988). |
Fujii et al., “Treatment for Delayed Brain Injury After Pituitary Irradiation,” Neurol. Surg., 16(3), 241-247 (1988). (English-language Abstract Only). |
Green et al., “Prevention of Thromboembolism after Spinal Cord Injury Using Low-Molecular-Weight Heparin,” Annal. Intern. Med., 113, 571-574 (1990). |
Kay et al., “Low-Molecular-Weight Heparin for the Treatment of Acute Ischemic Stroke,” New Eng. J. Med., 333(24), 1588-1593 (1995). |
DiStefano et al., “Low-Molecular-Weight Heparins for Long-Term Therapy of Peripheral Vascular Disease,” Therapeut, Res., 44(1), 1-9 (1988). |
Tzonos et al., “The Effect of Proteinasen and Fibrinolysis Inhibitors on Experimental Brain Edemo,” Z. Neurol., 205(1), 61-70 (1973). (English language abstract only). |